HOME >> BIOLOGY >> NEWS
Breathing easy: When it comes to oxygen, a bug's life is full of it

Washington Because of new imaging technology, researchers are getting a better understanding of a physiological paradox: how insects, which have a respiratory system built to provide quick access to a lot of oxygen, can survive for days without it.

The insect respiratory system is so efficient that resting insects stop taking in air as they release carbon dioxide, according to research by Stefan K. Hetz of Humboldt University in Berlin, Germany. This allows them to keep oxygen and carbon dioxide levels in balance. Too great a concentration of oxygen is toxic, causing oxidative damage to the insect's tissues, just as it does in humans.

Hetz is one of four speakers at the upcoming symposium "Respiratory control in insects: integration from the gene to the organism." The symposium, sponsored by The American Physiological Society (APS) takes place 10:30 a.m., Sunday, April 29 during the APS annual meeting at Experimental Biology 2007 in Room 147A, the Washington Convention Center in Washington, D.C. Scott Kirkton of Union College, Schenectady, New York, will lead the symposium of four speakers.

Why bugs don't pant

Bees consume large amounts of oxygen, and so it might be tempting to think they are panting tiny inaudible pants. They are not, because they do not breathe through noses or mouths. Instead, insects draw in oxygen through holes in their bodies known as spiracles and pump the oxygen through a system of increasingly tiny tubes (tracheae) that deliver oxygen directly to tissues and muscles. Insects typically have a pair of spiracles for each thoracic and abdominal segment.

The same tubes that transport oxygen into the insect body usher out carbon dioxide. Insects use different methods to release carbon dioxide, including opening the thoracic spiracles (the ones closest to the head) to take in oxygen while exhaling carbon dioxide through the abdominal spiracles. Insects also use different mechanisms to pump
'"/>

Contact: Chris Guilfoy
CGuilfoy@The-APS.org
301-634-7253
American Physiological Society
29-Apr-2007


Page: 1 2 3 4

Related biology news :

1. Breathing for better lung health
2. Scientists prove that disputed Korean stem cell line comes from an unfertilized egg and not cloning
3. Skin rash actually signifies better outcomes for pancreatic and lung cancer patients
4. Arctic spring comes weeks earlier than a decade ago
5. New algorithms classify outcomes of nonsmall cell lung cancer patients
6. When the villain becomes your friend: The strange tale of muscle lactate
7. Eavesdropping comes naturally to young song sparrows
8. Latent memory of cells comes to life
9. Nemo comes home with a tag
10. Improving outcomes in premature births
11. PNNL becomes DOE flagship for incentive-based waste management practices

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Breathing easy When comes oxygen bug life full

(Date:5/20/2013)... resistant to the antibiotic colistin are also commonly ... body, according to a study in mBio ... Society for Microbiology. Cross-resistance to colistin and host ... body against bacterial attack, could mean that patients ... with a crippled immune response. Colistin is a ...
(Date:5/20/2013)... Science Foundation (NSF) planning grant will help establish the ... program of the University of Illinois at Urbana-Champaign and ... will be devoted to research in drying moist, porous ... and paper products; chemical products; textiles; and biopharmaceuticals," said ... science and human nutrition and the Illinois site director. ...
(Date:5/19/2013)... strain of electricity-producing bacteria that can grow using hydrogen ... as its sole source of carbon. Researchers at ... the 113th General Meeting of the American Society for ... production solely on hydrogen," says Amit Kumar, a researcher ... part of the Lovley Lab Group at the university. ...
Breaking Biology News(10 mins):Resistance to last-line antibiotic makes bacteria resistant to immune system 2Resistance to last-line antibiotic makes bacteria resistant to immune system 3NSF approves planning grant for Center for Advanced Research in Drying 2
(Date:5/21/2013)... Raleigh, NC (PRWEB) May 21, 2013 ... and financial services company for clinical trials, announced ... Aggregate Spend Solutions, LLC. Clinverse’s ClinPay® FLS ... automated investigator payment process. SpendMD ™, ... only complete solution for tracking and reporting transfer ...
(Date:5/21/2013)... , May 21, 2013 According ... Research ( http://www.transparencymarketresearch.com ) "Biochip Products and Services Market ... - U.S. Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018," ... 2011 and is expected to grow at a CAGR ... estimated value of USD 4.7 billion in 2018. ...
(Date:5/21/2013)... 21, 2013 Many have long discussed ... to acne. Recently physicians from Clinical Psychiatry.com ... on the skin, and suggested using hypnotherapy ... chemicals produced from stress that cause acne. , Doctors ... feelings acne brings about, stress causes changes in the ...
(Date:5/21/2013)... ROCKVILLE, Md. , May 21, 2013 /PRNewswire/ ... "Phase 1 study of margetuximab (MGAH22), an Fc-modified ... solid tumors expressing the HER2 oncoprotein," will be ... American Society of Clinical Oncology during the Developmental ... June 3 at 4:15 – 4:30 PM.  The ...
Breaking Biology Technology:Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 2The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 4The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 5Adult Acne Treatment, Probiotic Action Explains How Hypnotherapy and Probiotics May Cure Various Skin Conditions 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3
Cached News: